Abstract
Experiments on superfused slices of rat hippocampus showed that the nootropic drugs pyracetam, ethymizol, ambocarb, and nooglutil increase the amplitude of populational EPSP (pEPSP) of neurons of the dentate gyrus evoked by electrical stimulation of the perforant pathway (PP). Nootropes exert no effect on the process of presynaptic glutamate liberation from the PP axons, but increase the chemosensitivity of the postsynaptic AMPA/kainate receptors mediating EPSP generation in the dentate gyrus neurons. Inhibitors of protein kinase (A-buthamide) and guanylatecyclase (methylene blue) do not modify the effects of nootropes. The nootrope-induced potentiation of pEPSP does not develop against the background of the application of calmodulin inhibitor W-7. In the presence of protein kinase inhibitor C, polymixin B, nootropes reversibly depress pEPSP in the dentate gyrus neurons. Blocking of the NMDA receptor ionic channels by ketamine and of the voltage-dependent T-type calcium channels by Ni2+ does not significantly modify the effects of nootropic drugs. A blocker of Ca2+-ATPase of the Ca2+ stores sodium orthovanadate, potentiates the effects of nootropes. Dantrolene, which disrupts Ca2+ liberation from the non-mitochondrical depots, blocks the effects of nootropes and diminishes pEPSP depression evoked by nootropes in the presence of polymixin B. On the basis of presented data, it is supposed that nootropic drugs assist Ca2+ liberation from the neuronal depots and activate calmodulin-dependent protein kinase and protein kinase C. Protein kinases phosphorylate the intracellular domains of the AMPA/kainate receptors, and this process results in an increase in their sensitivity to excitatory amino acids.
Similar content being viewed by others
References
G. I. Kovalev,Nootropic Drugs, Nizh.-Volzh. Knizhnoe Izdatel'stvo, Volgograd (1990).
M. Krug, M. Koch, E. Shoof, et al., “Methylglucamine orotate, a memory-improving drug, prolongs hippocampal long-term potentiation,”Eur. J. Pharmacol.,173, No. 2/3, 223–226 (1989).
A. J. Silva, C. F. Stevens, S. Tonegava, et al., “Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice,”Science, No. 5067, 201–206 (1992).
G. Tocco, A. J. Annala, M. Baudry, et al., “Learning of a hippocampal-dependent conditioning task changes the binding properties of AMPA receptors in rabbit hippocampus,”Behav. Biol.,58, No. 3, 222–231 (1992).
G. L. Collingridge, C. H. Davies, and K. G. Reyman, “Long-term potentiation in the rat hippocampal slicesin vitro is associated with a delayed increase in sensitivity ofCAI neurons to AMPA,”J. Physiol.,414, 23P (1989).
I. Ito, S. Tanabe, A. Kohda, et al., “Allosteric potentiation of quisqualate receptor by a nootropeic drug aniracetam,”J. Physiol.,424, 533–543 (1990).
J. D. C. Lambert and R. S. G. Jones “A reevaluation of excitatory amino acid mediated synaptic transmission in rat dentate gyrus,”J. Neurophysiol.,64, No. 1, 119–132 (1990).
J. Taube and P. A. Schwartzkrain, “Mechanisms of long-term potentiation: EPSP/spike dissociation intradendritic recording and glutamate sensitivity,”J. Neurosci.,8, No. 5, 1632–1644 (1988).
M. Marchi, E. Besanaa, and M. Raiteri, “Oxiracetam increases the release of endogenous glutamate from depolarized rat hippocampal slices,”Eur. J. Pharmacol.,185, No. 2/3, 247–249 (1990).
R. D. Sheridan and P. Saggan, “Optical monitoring of presynaptic calcium changes in fura-2 loaded hippocampal slice,”Pflügers. Arch.,413, Suppl., No. 1, 87 (1990).
J. A. Kauer, R. C. Malenka, and R. A. Nicoll, “NMDA application potentiates synaptic transmission in the hippocampus,”Nature,334, No. 6197, 250–252 (1988).
E. McGlademculoh, H. Yamamoto, S. E. Tan, et al., “Phosphorylation and regulation of glutamate receptors by calcium-calmodulin-dependent protein kinase II,”Nature,362, No. 6421, 640–642 (1993).
D. Madison and R. Nicoll, “Norepinephrine decreases synaptic inhibition in the rat hippocampus,”Brain Res.,442, No. 1, 131–138 (1988).
S. R. Glaum and R. J. Miller, “Activation of metabotropic glutamate receptors produced reciprocal regulation of iontotropic glutamate and GABA responses in the nucleus of the tractus solitarius,”J. Neurosci.,13, No. 4, 1636–1641 (1993).
A. Ambrosini and J. Meldolesi, “Muscarinic and quisqualate receptor induced phosphoinositide hydrolysis in primary cultures striatal and hippocampal neurons. Evidence for differential mechanism of activation,”J. Neurochem.,53, No. 3, 825–833 (1989).
D. D. Schoep, “Protein kinase C-mediated inhibition of excitatory amino acid stimulated phosphoinositide hydrolysis in the neonatal rat hippocampus,”Neurochem. Int.,15, No. 2, 131–136 (1989).
G. G. S. Collins and W. J. Richards, “Pharmacological evidence that protein kinase C modulates monosynaptic excitations in the olphactory cortex,”Naunyn-Schmiedeberg's Arch. Pharmacol.,341, No. 1/2, 114–122 (1990).
M. Sakurai, “Effect of intracellular injection of EGTA on synaptic plasticity in the cerebellar cortex,”Neuroscience,5, Suppl., No. 7, 77 (1988).
G. Pepe and G. Spignoli, “Nootropic drugs and brain cholinergic mechanisms,”Prog. Neuro-Psychopharmacol. Biol. Psychiat.,13, Suppl., 77–88 (1989).
I. I. Abramets, I. I. Komissarov, and I. V. Samoilovich, “Multiple mechanisms underlying nootropic drug-induced enhancement of neuronal responses mediated by activation of glutamate NMDA-type receptors,”Neirofiziologiya/Neurophysiology,1, No. 3, 179–184 (1993).
R. Valinow, D. V. Madison, and R. W. Tsien, “Persistent protein kinase activity underlying long-term potentiation,”Nature,335, No. 6193, 820–824 (1988).
E. Klann, C. E. Chen, and J. D. Sweatt, “Persistent protein kinase activation in the maintenance phase of long-term potentiation,”J. Biol. Chem.,226, No. 36, 24253–24256 (1991).
Author information
Authors and Affiliations
Additional information
Neirofiziologiya/Neurophysiology, Vol. 26, No. 5, pp. 365–372, September–October, 1994.
Rights and permissions
About this article
Cite this article
Abramets, I.I., Andreev, P.V., Komissarov, I.V. et al. Neuronal responses mediated by activation of the non-NMDA receptors: Potentiation by nootropes. Neurophysiology 26, 301–306 (1994). https://doi.org/10.1007/BF01058509
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01058509